诱导中度DNA损伤可增强巨核细胞生成与血小板产生
该研究在小鼠中给予PARP抑制剂尼拉帕利,发现高剂量导致血小板减少,而低剂量则显著增加骨髓巨核细胞、巨核祖细胞及循环血小板,并伴DNA损伤标志升高;低剂量γ射线照射亦产生类似效应,提示中度DNA损伤是增强巨核细胞生成和血小板计数的保守机制。
要点
- 低剂量尼拉帕利使小鼠骨髓巨核细胞、巨核祖细胞及循环血小板显著增加。
- 该增加伴随巨核细胞和巨核祖细胞中γH2AX累积及彗星试验所示的DNA损伤升高。
- 低剂量γ射线照射同样引起巨核细胞DNA损伤并增加巨核细胞和血小板计数。
核心结论
- 中度DNA损伤可增强巨核细胞生成并提高血小板计数,提示巨核细胞与DNA损伤之间存在此前未知的关系,并呈现为触发体内血小板生成增多的新靶点。
研究设计与样本
- 研究为小鼠实验,给予PARP抑制剂尼拉帕利,并另以低剂量γ射线照射处理小鼠。
主要发现
- 高剂量尼拉帕利处理导致小鼠血小板减少,与临床观察一致。
- 较低剂量尼拉帕利处理导致小鼠骨髓巨核细胞、巨核祖细胞及循环血小板显著增加。
- 尼拉帕利处理小鼠的血小板对ADP、凝血酶受体激活肽和胶原的反应功能正常。
- 低剂量γ射线照射小鼠同样导致巨核细胞DNA损伤,并增加巨核细胞和血小板计数。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Megakaryocytes (MKs) are large, hematopoietic cells with a polyploid, multilobulated nucleus. Although DNA replication in MKs (endomitosis) is well studied, limited investigations have examined the impact of DNA instability on megakaryopoiesis. Poly-adenosine diphosphate (ADP) ribose polymerase (PARP) inhibitors are chemotherapeutics that result in accumulation of DNA damage and are commonly associated with thrombocytopenia, presumably mediated through platelet progenitors, MKs. To explore PARP inhibitor-induced thrombocytopenia, we treated mice with the PARP inhibitor niraparib. Although high-dose niraparib treatment led to thrombocytopenia, consistent with clinical observations, lower-dose treatment led to a significant increase in bone marrow MKs, MK progenitors (MkPs), and circulating platelets. This increase was accompanied by elevated DNA damage in both MKs and MkPs, as measured by γH2AX accumulation and comet assays. Notably, platelets from niraparib-treated mice were functionally normal in their response to ADP, thrombin receptor activating peptide, and collagen. Treatment of mice with low-dose gamma irradiation similarly led to DNA damage in MKs and resulted in increased MK and platelet counts, suggesting that moderate DNA damage is a conserved mechanism that enhances megakaryopoiesis and platelet counts. These data reveal a previously unknown relationship between MKs and DNA damage and present a novel target for triggering enhanced platelet production in vivo.
引用
- Camacho V, Bekendam RH, Stone AP, et al. Induction of moderate DNA damage enhances megakaryopoiesis and platelet production. Blood Adv. 2026. PMID: 40938731. doi:10.1182/bloodadvances.2025017375
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。